Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Speculating in Takeover Targets -- Ignore unavailable to you. Want to Upgrade?

To: richardred who wrote (2568)	11/30/2010 2:48:18 PM
From: Grantcw	Read Replies (1) \| Respond to of 7243

I joined in the speculation on SVNT here at 12.32, albeit with a 12.5 Jan Covered call for 1.30. They announced pricing of their product today, so maybe as things progress the company will look more attractive? Thanks, cwillyg

To: richardred who wrote (2568)	12/28/2010 7:13:40 PM
From: Grantcw	Read Replies (1) \| Respond to of 7243

I'm still liking SVNT, but it sure looks like they're going it alone given today's CEO search announcement. The nice thing about this company is that it doesn't look like they need to get too many patients using their new drug to justify the current market cap at their projected drug pricing. I've got about a 5% position in SVNT, writing 12.50 and 12.00 calls right now in Jan and March on 4% of my position, with 1% in there uncovered. So, I'm liking this company as a speculative risk/reward play. We'll see how it turns out. Thanks, Grant